West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2023 Earnings Conference Call October 26, 2023 9:00 AM ET Company Participants Quintin Lai - Vice President of Investor Relations Eric Green - President & Chief Executive Officer Conference Call Participants Paul Knight - KeyBanc Capital Markets Larry Solow - CJS Securities Jacob Johnson - Stephens John Sourbeer - UBS Matt Larew - William Blair David Windley - Jefferies Justin Bowers - Deutsche Bank Derik De Bruin - Bank of America Operator Good day, and than ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2023 Earnings Conference Call July 27, 2023 9:00 AM ET Company Participants Quintin Lai - Vice President of Investor Relations Eric Green - President & Chief Executive Officer Bernard Birkett - Senior Vice President and Chief Financial & Operations Officer Conference Call Participants Larry Solow - CJS Jacob Johnson - Stephens Paul Knight - KeyBanc Derik De Bruin - Bank of America Matthew Larew - William Blair David Windley - Jefferies John Sourbeer - UBS Jus ...

Second-Quarter 2023 WST Q2 2023 Earnings 1 | --- | --- | |-------------------------------------------------------------------------------|-------| | Second Quarter Overall Net Sales $753.8M \| 2.3% | | | | | | Diluted Earnings Per Share: $2.06 Adjusted Diluted Earnings Per Share: $2.11 | | "We had a solid first-half of 2023, and with the momentum of our high-value product capacity expansion projects, we are well positioned for an even better second-half of the year. While COVID-19 related sales continued to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-8036 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 23-1210010 (State or ot ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2023 Results Conference Call April 27, 2023 9:00 AM ET Company Participants Quintin Lai - IR Eric Green - CEO Bernard Birkett - CFO Conference Call Participants Larry Solow - CJS Securities Paul Knight - KeyBanc Capital Markets Matt Larew - William Blair Jacob Johnson - Stephens Derik De Bruin - Bank of America John Sourbeer - UBS Quintin Lai [Call Starts Abruptly] …conference call. We issued our financial results this morning, and the release has been posted ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 530 Herman O. West Drive, Exton, PA 19341-0645 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 610-594-2900 Securities re ...

| --- | --- | --- | |---------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | West Pharmaceutical Services, Inc. | | | | Eric M. Green | | | | President, CEO and Chair of the Board | | | March 2023 Investor Conferences Safe Harbor Statement Cautionary Statement Under the Private Securities Litigation Reform Act of 1995 This presentation and any accompanying management commentary contain "forwardlooking statements" as that term is defined in the Private Securities Litigation ...

Workforce and Employment - The company employed approximately 10,700 people as of December 31, 2022, with an attrition rate of approximately 22%[46] - The company hired approximately 2,850 new team members in 2022, reflecting ongoing growth in its workforce[46] - The company has a global workforce gender demographic of 64% men and 36% women as of December 31, 2022[47] - The company actively fosters an inclusive culture, with four out of ten members of its Leadership Team being women as of December 31, 2022[48] - The company offers approximately 42,000 courses through its Learning Management System to support continuous learning and development[49] - The company is committed to fair and competitive compensation, providing a comprehensive total rewards program for its employees[52] Customer and Sales - The company's ten largest customers accounted for 45.6% of consolidated net sales in 2022, with no individual customer exceeding 10%[34] Innovation and Intellectual Property - In 2022, more than 150 patents were issued to the company globally, highlighting its focus on intellectual property[27] - In 2022, the company was issued more than 150 patents globally, highlighting its commitment to innovation and intellectual property[27] - The company continues to pursue strategic initiatives in drug containment components and novel drug delivery devices[42] Health and Safety - The company's Recordable Injury Rate in 2022 was 0.67 per 100 employees, indicating a commitment to health and safety[53] - The Recordable Injury Rate for the company in 2022 was 0.67 per 100 employees, reflecting its focus on health and safety[53] Supply Chain Management - The company has maintained adequate supplies of raw materials through agreements with suppliers, managing inventory levels to mitigate supply chain risks[24] - The company has a supply chain management strategy that relies on single-source suppliers for many critical raw materials, increasing supply chain risk[25] Environmental, Social, and Governance (ESG) - West has been committed to ESG topics for many years, focusing on talent attraction, retention, and engagement, including diversity and inclusivity efforts[55] - The company has implemented a climate and greenhouse gas reduction strategy that incorporates renewable energy and aims to reduce absolute and intensity emissions[55] - West is developing a more sustainable supply chain and focusing on research and development related to sustainability, including secondary packaging and recyclability[55] - Philanthropic programs are essential to corporate citizenship, with a focus on children's health, access to healthcare, and STEM education, while expanding to include sustainability initiatives[55] - The company solicits employee input on improving ESG areas, viewing progress as critical for maintaining an engaged workforce[55] Regulatory Compliance - The company has not required material capital expenditures for compliance with government regulations in 2022 and does not expect significant expenditures in 2023[29]

West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2022 Earnings Conference Call February 16, 2023 9:00 AM ET Company Participants Quintin Lai - VP, Strategy & IR Eric Green - Chair, President & CEO Bernard Birkett - SVP and Chief Financial & Operations Officer Conference Call Participants Lawrence Solow - CJS Securities Matthew Larew - William Blair & Company Jacob Johnson - Stephens Inc. John Sourbeer - UBS Derik De Bruin - Bank of America Merrill Lynch Paul Knight - KeyBanc Capital Markets David Windley - ...

Fourth-Quarter 2022 and Full Year Results WST Q4/FY 2022 Earnings 1 Fourth Quarter Overall Net Sales $708.7M | 3.0% Diluted Earnings Per Share: $1.36 Adjusted Diluted Earnings Per Share: $1.77 "I am pleased to report that we had a solid finish to 2022 and that we enter 2023 with a strong order book and continued demand for our core business. I am extremely proud of the many accomplishments by our global team members, as our Company has supplied critical components, solutions and systems to our base and COVI ...